Business Process Outsourcing
PRODUCTS
-
Global solutions tailored for your unique needs.
-
Gain expert guidance and connect with a global network of qualified QPPVs and LPPVs, who will ensure compliance with pharmacovigilance regulations and tailor their approach to your product launch strategy.
-
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
The Class 2, Type B2 Laminar Flow Biosafety Cabinet provides a high degree of localized protection from particulate and aerosol hazards. The work area is continuously bathed with laminar flow ISO 5/Class 100 HEPA-filtered air while creating a negative pressure airflow into the cabinet to provide user protection.
-
Versatile CCIT1 for a wide range of applications
The SpeedAir 3050 is your all-in-one solution for nonporous pharmaceutical applications. Whether your products are flexible or rigid, liquid or solid, the SpeedAir 3050 can swiftly and accurately test them all. With testing times as short as 30-45 seconds, it delivers results you can rely on, ensuring the integrity of your pharmaceutical containers.
WHITE PAPERS AND CASE STUDIES
-
Strategic Clinical Trial Design Unlocks Innovative Funding Opportunity
A small biotech sponsor developing a new treatment for carcinoma asked for assistance with their trial design. Working with a constrained R&D budget, the challenge was to gather the evidence in a cost-effective manner and use a stage-gate approach for the funding. Explore the solutions uncovered in this case study.
-
Simplify CAPA In 7 Steps
Discover how to streamline corrective action/preventive action (CAPA) management in regulatory environments in 7 steps.
-
Automated Data Capture To Train An AI Algorithm With eSource
Explore why an AI algorithm needs a steady and significant stream of data to become more accurate and prove its efficacy in a clinical setting.
-
Risk Assessment As A Process Quality Assurance Tool
Discover how an effective approach to risk management can further ensure the delivery of a high-quality drug or medicine to the patient.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer
What immune checkpoint inhibitors are showing promise in cervical cancer treatments and how are advancements in treatment, paired with additional prevention strategies, improving patient outcomes?
-
The City Of Fayetteville's Flood Resiliency In The Face Of Climate Change: Mapping 15 Watersheds
The city of Fayetteville, North Carolina has always had flooding issues, but it’s been getting worse as weather patterns have been changing. They were hit four years in a row by storms Matthew (2016), Irma (2017), Florence (2018), and Dorian (2019).
-
Using A Fixed Bed Reactor System For Expansion Of Human Embryonic Stem Cells
Regenerative medicine company ViaCyte Inc. explored new technologies to enable expanded scales of culturing hESCs for development of cell replacement therapies as a functional cure for Type 1 diabetes.
-
Doubling The Speed Of Cell Line Development In A Large Pharmaceutical Company
We explore how the Cell Line Development group at Janssen R&D was able to reduce one of their development processes to a single step thanks to new technology.
-
Benefits Of Implementing EDC & Medical Coding With RTSM
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Preparing A New Drug Application (NDA) With A CDISC Conversion
Regulatory submissions are the most critical milestones in clinical research programs. Learn how quality submissions can accelerate time to market, maximize research investments and bring the benefit of new treatments to patients sooner.
-
The Digitalization Of Biopharma Process Development, Manufacturing
The fourth industrial revolution is coming. Explore the three essentials of bioprocess development and manufacturing digitalization: digital literacy, digital trust, and prioritization.
-
Reimagining FSP With ProPharma's RCO Model
Begin leveraging our Research Consulting Organization (RCO) model and gain access to customized, agile, and scalable solutions that continuously evolve to meet your unique needs.
NEWS
-
Cancer Drug Discovery Accelerated As Hundreds Of Overlooked Targets Prioritised1/11/2024
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
-
Q32 Bio And Homology Medicines Announce Merger Agreement11/16/2023
Q32 Bio Inc., a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, and Homology Medicines, Inc. (Nasdaq: FIXX), today announced they have entered into a definitive merger agreement to combine the companies in an all-stock transaction.
-
Lenacapavir: Drug Offers New Hope For Multi-Drug Resistant HIV8/29/2023
Onyema Ogbuagu, MD, gets excited about finding new ways to treat HIV—and he is very enthusiastic about lenacapavir, an injection recently approved by the FDA for multi-drug resistant HIV for which he was the principal investigator.
-
The FDA's Proposed Ruling On Lab Tests Could Have Unintended Consequences2/6/2024
Yale experts are raising concerns about a rule proposed by the U.S. Food and Drug Administration (FDA) to enforce the agency’s regulatory control over laboratory-developed tests, or LDTs. The tests play a critical role in filling gaps in commercial testing, such as diagnostic tests for rare diseases deemed unprofitable by manufacturers.
-
eureKING, The First European SPAC In Healthcare Dedicated To Biomanufacturing, Announces The Signature Of A Put Option For The Potential Acquisition Of Skyepharma To Build A New European Bio-CDMO Leader5/30/2023
eureKING (ISIN: FR0014009ON9, Euronext Paris), the first European special purpose acquisition company (“SPAC”) in healthcare dedicated to bioproduction, today announced that it has signed, on May 25, 2023, a put option agreement for 100% of the share capital of Oleron Pharma, the 100% holding company of Skyepharma.